Production and glycosylation of recombinant β-interferon in suspension and cytopore microcarrier cultures of CHO cells

Biotechnology Progress

Volumn 21, Issue 1, 2005, Pages 31-39

  Spearman, Maureen ^a   Rodriguez, Jose ^a   Huzel, Norm ^a   Butler, Michael ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLOMERATION; GROWTH KINETICS; PROTEINS; SURFACE CHEMISTRY; SUSPENSIONS (FLUIDS);

BIOPROCESS DEVELOPMENTS; CYTOPORE MICROCARRIERS; ELISA METHODS; RECOMBINANT GLYCOPROTEINS;

CELL CULTURE;

BETA INTERFERON; MICROSPHERE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CHO CELL; CULTURE MEDIUM; CULTURE TECHNIQUE; DRUG EFFECT; GLYCOSYLATION; HAMSTER; HUMAN; INSTRUMENTATION; ISOLATION AND PURIFICATION; METHODOLOGY; POROSITY; SUSPENSION; TIME;

ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CHO CELLS; CRICETINAE; CULTURE MEDIA; CULTURE TECHNIQUES; GLYCOSYLATION; HUMANS; INTERFERON-BETA; MICROSPHERES; POROSITY; RECOMBINANT PROTEINS; SUSPENSIONS; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 13544272716     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp0498084     Document Type: Article

References (41)

1. Chu, L.; Robinson, D. K. Industrial choices for protein production by large-scale cell culture. Curr. Opin. Biotechnol. 2001, 12, 180-187.
2. Wu, S. C.; Huang, G. Y.; Liu, J. H. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture. Biotechnol. Prog. 2002, 18, 617-622.
3. Kallel, H.; Rourou, S.; Majoul, S.; Loukil, H. A novel process for the production of a veterinary rabies vaccine in BHK-21 cells grown on microcarriers in a 20-L bioreactor. Appl. Microbiol. Biotechnol. 2003, 61, 441-446.
4. Liu, C. C.; Wu, S. C. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate. Biotechnol. Bioeng. 2004, 86, 482-488.
5. Butler, M.; Burgener, A.; Patrick, M.; Berry, M.; Moffatt, D.; Huzel, N.; Barnabe, N.; Coombs, K. Application of a serum-free medium for the growth of Vero cells and the production of reovirus. Biotechnol. Prog. 2000, 16, 854-858.
6. Cosgrove, L.; Lovrecz, G. O.; Verkuylen, A.; Cavaleri, L.; Black, L. A.; Bentley, J. D.; Howlett, G. J.; Gray, P. P.; Ward, C. W.; McKern, N. M. Purification and properties of insulin receptor ectodomain from large-scale mammalian cell culture. Protein Expression Purif. 1995, 6, 789-798.
7. Thotakura, N.; Desai, R.; Bates, L.; Cole, E.; Pratt, B.; Weintraub, B. Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology 1991, 128, 341-348.
8. Malda, J.; van Blitterswijk, C. A.; Grojec, M.; Martens, D. E.; Tramper, J.; Riesle, J. Expansion of bovine chondrocytes on microcarriers enhances redifferentiation. Tissue Eng. 2003, 9, 939-948.
9. Martin, T. A.; Harding, K. G.; Jiang, W. G. Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts. Angiogenesis 1999, 3, 69-76.
10. Tao, X.; Saholin, L.; Yaoting, Y. Preparation and culture of hepatocyte on gelatin microcarriers. J. Biomed. Mater. Res. 2003, 65A, 307-310.
11. Yokomizo, A. Y.; Antoniazzi, M. M.; Galdino, P. L.; Azambuja, N., Jr.; Jorge, S. A.; Pereira, C. A. Rabies virus production in high Vero cell density cultures on macroporous microcarriers. Biotechnol. Bioeng. 2004, 85, 506-515.
12. Wu, S.; Hsieh, W.; Liau, M. Comparisons of microcarrier cell culture processes in one hundred milliliter spinner flask and fifteen liter bioreactor cultures. Bioprocess Eng. 1998, 19, 431-434.
13. Wang, M. D.; Yang, M.; Huzel, N.; Butler, M. Erythropoietin production from CHO cells grown by continuous culture in a fluidized-bed bioreactor. Biotechnol. Bioeng. 2002, 77, 194-203.
14. Ng, Y.-C.; Berry, J. M.; Butler, M. Optimization of physical parameters for cell attachment and growth on macroporous microcarriers. Biotechnol. Bioeng. 1996, 50, 627-635.
15. Watson, E.; Shah, B.; Leiderman, L.; Hsu, Y. R.; Karkare, S.; Lu, H. S.; Lin, F. K. Comparison of N-linked oligosaccharides of recombinant human tissue kallikrein produced by Chinese hamster ovary cells on microcarrier beads and in serum-free suspension culture. Biotechnol. Prog. 1994, 10, 39-44.
16. Goldman, M. H.; James, D. C.; Rendall, M.; Ison, A. P.; Hoare, M.; Bull, A. T. Monitoring recombinant human interferon-gamma N-glycosylation during perfused fluidized-bed and stirred-tank batch culture of CHO cells. Biotechnol. Bioeng. 1998, 60, 596-607.
17. Schweikart, F.; Jones, R.; Jaton, J. C.; Hughes, G. J. Rapid structural characterisation of a murine monoclonal IgA alpha chain: heterogeneity in the oligosaccharide structures at a specific site in samples produced in different bioreactor systems. J. Biotechnol. 1999, 69, 191-201.
18. Xiao, C. H., Z.; Wengqing, L.; Hu, X.; Qu, W.; Gao, L.; Liu, G. High Density and scale-up cultivation of recombinant CHO cell line and hybridomas with porous microcarrier Cytopore. Cytotechnology 1999, 30, 143-147.
19. Ikonomou, L.; Drugmand, J. C.; Bastin, G.; Schneider, Y. J.; Agathos, S. N. Microcarrier culture of lepidopteran cell lines: implications for growth and recombinant protein production. Biotechnol. Prog. 2002, 18, 1345-1355.
20. Filippini, G.; Munari, L.; Incorvaia, B.; Ebers, G. C.; Polman, C.; D'Amico, R.; Rice, G. P. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 2003, 361, 545-552.
21. Chofflon, M.; Ben-Amor, A. F. Long-term benefits of early and high doses of interferon beta-1a treatment in relapsing-remitting multiple sclerosis. Clin. Neurol. Neurosurg. 2002, 104, 244-248.
22. Arnason, B. G. Treatment of multiple sclerosis with interferon beta. Biomed. Pharmacother. 1999, 53, 344-350.
23. Fernandez, O.; Mayorga, C.; Luque, G.; Guerrero, M.; Guerrero, R.; Leyva, L.; Leon, A.; Blanca, M. Study of binding and neutralising antibodies to interferon-beta in two groups of relapsing-remitting multiple sclerosis patients. J. Neurol. 2001, 248, 383-388.
24. Sorensen, P. S.; Ross, C.; Clemmesen, K. M.; Bendtzen, K.; Frederiksen, J. L.; Jensen, K.; Kristensen, O.; Petersen, T.; Rasmussen, S.; Ravnborg, M.; Stenager, E.; Koch-Henriksen, N. Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. Lancet 2003, 362, 1184-1191.
25. Antonetti, F.; Finocchiaro, O.; Mascia, M.; Terlizzese, M. G.; Jaber, A. A comparison of the biologic activity of two recombinant IFN-beta preparations used in the treatment of relapsing-remitting multiple sclerosis. J. Interferon Cytokine Res. 2002, 22, 1181-1184.
26. Runkel, L.; Meier, W.; Pepinsky, R. B.; Karpusas, M.; Whitty, A.; Kimball, K.; Brickelmaier, M.; Muldowney, C.; Jones, W.; Goelz, S. E. Structural and functional differences between glycosylated and nonglycosylated forms of human interferon-beta (IFN-beta). Pharm. Res. 1998, 15, 641-649.
27. Kasama, K.; Utsumi, J.; Matsuo-Ogawa, E.; Nagahata, T.; Kagawa, Y.; Yamazaki, S.; Satoh, Y. Pharmacokinetics and biologic activities of human native and asialointerferon-beta s. J. Interferon Cytokine Res. 1995, 15, 407-415.
28. Kagawa, Y.; Takasaki, S.; Utsumi, J.; Hosoi, K.; Shimizu, H.; Kochibe, N.; Kobata, A. Comparative study of the asparagine-linked sugar chains of natural human interferon-beta 1 and recombinant human interferon-beta 1 produced by three different mammalian cells. J. Biol. Chem. 1988, 263, 17508-17515.
29. Utsumi, J.; Mizuno, Y.; Hosoi, K.; Okano, K.; Sawada, R.; Kajitani, M.; Sakai, I.; Naruto, M.; Shimizu, H. Characterization of four different mammalian-cell-derived recombinant human interferon-beta 1s. Identical polypeptides and non-identical carbohydrate moieties compared to natural ones. Eur. J. Biochem. 1989, 181, 545-553.
30. Berry, J.; Huebner, E.; Butler, M. The crystal violet nuclei staining technique leads to anomalous results in monitoring mammalian cell cultures. Cytotechnology 1996, 21, 73-80.
31. Kuster, B.; Wheeler, S. F.; Hunter, A. P.; Dwek, R. A.; Harvey, D. J. Sequencing of N-linked oligosaccharides directly from protein gels: in-gel deglycosylation followed by matrix-assisted laser desorption/ionization mass spectrometry and normal-phase high-performance liquid chromatography. Anal. Biochem. 1997, 250, 82-101.
32. Bigge, J. C.; Patel, T. P.; Bruce, J. A.; Goulding, P. N.; Charles, S. M.; Parekh, R. B. Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid. Anal. Biochem. 1995, 230, 229-238.
33. Guile, G. R.; Rudd, P. M.; Wing, D. R.; Prime, S. B.; Dwek, R. A. A rapid high-resolution high-performance liquid chromatographic method for separating glycan mixtures and analyzing oligosaccharide profiles. Anal. Biochem. 1996, 240, 210-226.
34. Renard, J. S., R.; Macier, C.; Salles, M.; Mandine, E. Evidence that monoclonal antibody production kinetics is related to the integral of the viable cells curve in batch systems. Biotechnol. Lett. 1988, 10, 91-96.
35. Utsumi, J.; Yamazaki, S.; Kawaguchi, K.; Kimura, S.; Shimizu, H. Stability of human interferon-beta 1: oligomeric human interferon-beta 1 is inactive but is reactivated by monomerization. Biochim. Biophys. Acta 1989, 998, 167-172.
36. Conradt, H. S.; Egge, H.; Peter-Katalinic, J.; Reiser, W.; Siklosi, T.; Schaper, K. Structure of the carbohydrate moiety of human interferon-beta secreted by a recombinant Chinese hamster ovary cell line. J. Biol. Chem. 1987, 262, 14600-14605.
37. Utsumi, J.; Matsuo-Ogawa, E.; Nagahata, T.; Kasama, K.; Kagawa, Y.; Satoh, Y. Carbohydrate-dependent biological activities of glycosylated human interferon-beta on human hepatoblastoma cells in vitro. Microbiol. Immunol. 1995, 39, 81-86.
38. Yang, M.; Butler, M. Effects of ammonia and glucosamine on the heterogeneity of erythropoietin glycoforms. Biotechnol. Prog. 2002, 18, 129-138.
39. Gawlitzek, M.; Ryll, T.; Lofgren, J.; Sliwkowski, M. B. Ammonium alters N-glycan structures of recombinant TNFR-IgG: degradative versus biosynthetic mechanisms. Biotechnol. Bioeng. 2000, 68, 637-646.
40. Borys, M. C.; Linzer, D. I.; Papoutsakis, E. T. Culture pH affects expression rates and glycosylation of recombinant mouse placental lactogen proteins by Chinese hamster ovary (CHO) cells. Bio/Technology 1993, 11, 720-724.
41. Preissmann, A.; Wiesmann, R.; Buchholz, R.; Werner, R.; Noe, W. Investigations on oxygen limitations of adherent cells growing on macroprous microcarriers. Cytotechnology 1997, 24, 121-134.